Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
Rheumatology International|August 15, 2013
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsKatinka Albrecht, Klaus Krüger, Jürgen Wollenhaupt, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
Journal of Clinical Medicine|June 10, 2023
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO TrialMarlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2023
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung diseaseBas Smits, Sigune Goldacker, Suranjith Seneviratne, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Pageof 11